Wednesday, September 16, 2026Latest filing Sep 14, 2026

COLPAL Congressional Stock Trades

COLGATE PALMOLIVE LTD.

Last disclosed trade Apr 8

Every disclosed trade in COLPAL by members of Congress under the STOCK Act, parsed by Coldpine. Informational only, sourced from public filings. Not investment advice.

Sample · the intelligence layer

Coldpine signal scoreA 0-1 composite from four weighted factors: disclosure speed, trade size, cluster activity (multiple members buying the same name), and the member’s track record. ≥ 0.65 is the high-conviction tier; ≥ 0.50 is moderate. Trades from trust-managed members are penalized (× 0.2 multiplier). It’s research, not a recommendation.

John Boozman · Bought $COLPAL · Apr 8 · $1K–$15K

0.28LOW
Disclosure speedx 0.250.10
Trade sizex 0.250.20
Cluster activityx 0.150.00
Track recordx 0.350.57

Every disclosed trade in the database gets this treatment: a four-factor score and a written read from Coldpine’s AI-based analysis. Informational only, not investment advice. Create a free account for every scored trade →

Follow $COLPAL

Get notified when any member of Congress trades $COLPAL. Free, no card, no spam.

Follow free →
1
Disclosed trades
1
Buys
0
Sells
1
Members trading

The record on $COLPAL

Coldpine has parsed 1 disclosed trade in $COLPAL by 1 member of Congress, drawn from 1 periodic transaction report dated Apr 8, 2025. It came from the Senate, filed by a Republican.

The one trade with a known filing lag was reported 499 days after the trade date, outside the 45-day window the STOCK Act sets: a $COLPAL purchase by John Boozman dated Apr 8, 2025, disclosed Aug 20, 2026. How late filing is measured across all of Congress is in the late-filers study.

The one trade that lists an account holder was reported under a spouse, dependent child, or joint account rather than the member directly.

Members who trade COLPAL

Recent disclosed trades in COLPAL

DateMemberTypeAmount
Apr 8John Boozman(AR)buy$1K–$15K

Data sourced from public STOCK Act disclosures. Coldpine is a publisher of intelligence on congressional disclosures, not an investment adviser. See full history and scores, free with an account →